SCHEMBL64947

SCHEMBL64947

NC(=O)C1CC=CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3648373 0.80
SCHEMBL22323276 0.78
SCHEMBL4067739 0.73
SCHEMBL25301950 0.70 MAPK1 (0.34)
SCHEMBL17228790 0.67 ABAT (0.35)
SCHEMBL6422017 0.66
SCHEMBL6267384 0.64 SMN1; SMN2 (0.41)
SCHEMBL7495038 0.64
SCHEMBL7417349 0.64 TSHR (0.46)
SCHEMBL16587928 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020123563-A1 ENGINEERED POLYPEPTIDES THAT EXHIBIT INCREASED CATALYTIC EFFICIENCY FOR UNNATURAL COFACTORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-06-18 WO claimed
CN-105339350-B Dihydropyridone MGAT2 inhibitor 百时美施贵宝公司 2018-05-25 CN claimed
CN-102060857-A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA SPA 2011-05-18 CN claimed
CN-1447810-A Bicyclic pyrazoles with kinase inhibitor activity, process for their preparation and pharmaceutical compositions containing them PHARMACIA ITALIA SPA (IT) 2003-10-08 CN claimed
EP-0083378-A1 Tetrahydronicotinamide derivatives, a process for producing the same and a pharmaceutical composition comprising the same Chugai Seiyaku Kabushiki Kaisha (JP) 1983-07-13 EP claimed
US-4361572-A Tetrahydronicotinamide derivative, pharmaceutical compositions and use CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1982-11-30 US claimed
EP-4466266-A1 FUSED HETEROCYCLES AS 5-HT2A RECEPTOR AGONISTS Transneural Therapeutics, Inc. (US) 2024-11-27 EP disclosed
WO-2024048778-A1 ARYLTETRAHYDROPYRIDINE COMPOUND AND PEST CONTROL AGENT 日産化学株式会社 2024-03-07 WO disclosed
WO-2023141225-A1 FUSED HETEROCYCLES AS 5-HT2A RECEPTOR AGONISTS ONSERO THERAPEUTICS INC. (US) 2023-07-27 WO disclosed
CN-105793239-B Ultraviolet absorption compound, its composition and application thereof 珊瑚防晒私人有限公司 2019-11-05 CN disclosed
CN-106458897-A Process for producing heterocyclic compound 武田药品工业株式会社 2017-02-22 CN disclosed
US-8980907-B2 Dendrimer conjugates THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2015-03-17 US disclosed
US-8889635-B2 Dendrimer conjugates THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-11-18 US disclosed
US-8129538-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-06 US disclosed
CN-102060857-A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA SPA 2011-05-18 CN disclosed
US-20100160299-A1 DENDRIMER CONJUGATES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-06-24 US disclosed
WO-2010039861-A2 DENDRIMER CONJUGATES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-04-08 WO disclosed
CN-1447810-A Bicyclic pyrazoles with kinase inhibitor activity, process for their preparation and pharmaceutical compositions containing them PHARMACIA ITALIA SPA (IT) 2003-10-08 CN disclosed
EP-0083378-A1 Tetrahydronicotinamide derivatives, a process for producing the same and a pharmaceutical composition comprising the same Chugai Seiyaku Kabushiki Kaisha (JP) 1983-07-13 EP disclosed
US-4361572-A Tetrahydronicotinamide derivative, pharmaceutical compositions and use CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1982-11-30 US disclosed